AC
HAE icon

Arjuna Capital’s Haemonetics HAE Stock Holding History

Arjuna Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,642
Closed -$1.94M – 107
2023
Q4 		$1.94M Buy
22,642
+1,638
+8% +$142K 0.61% 49
2023
Q3 		$1.88M Buy
21,004
+326
+2% +$29.1K 0.67% 49
2023
Q2 		$1.76M Buy
20,678
+357
+2% +$30.2K 0.62% 48
2023
Q1 		$1.68M Sell
20,321
-6,452
-24% -$522K 0.66% 47
2022
Q4 		$2.11M Buy
26,773
+830
+3% +$66.7K 0.97% 35
2022
Q3 		$1.92M Buy
+25,943
New +$1.86M 0.94% 31
2020
Q2 		– Sell
-4,972
Closed -$496K – 94
2020
Q1 		$496K Buy
4,972
+632
+15% +$68.5K 0.41% 61
2019
Q4 		$499K Buy
4,340
+428
+11% +$51.8K 0.36% 71
2019
Q3 		$493K Buy
3,912
+235
+6% +$29.8K 0.42% 57
2019
Q2 		$442K Buy
3,677
+667
+22% +$65.6K 0.32% 74
2019
Q1 		$263K Buy
3,010
+485
+19% +$44.1K 0.2% 84
2018
Q4 		$253K Buy
2,525
+73
+3% +$7.67K 0.23% 84
2018
Q3 		$281K Sell
2,452
-42
-2% -$4.35K 0.21% 84
2018
Q2 		$224K Buy
+2,494
New +$211K 0.18% 84

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arjuna Capital's HAE Position: Q1 2024 in Review

Arjuna Capital sold out of Haemonetics (HAE) in Q1 2024, closing a stake of 22,642 shares — an estimated $1.94M sold.

Arjuna Capital first reported a position in HAE in Q2 2018 and held it in 14 quarters. The position peaked at $2.11M in Q4 2022. 298 funds tracked by Wall St. Rank hold HAE as of Q1 2024.

  • Arjuna Capital reported no remaining Haemonetics position as of Q1 2024 after selling out during the quarter.
  • Arjuna Capital sold 22,642 Haemonetics shares in Q1 2024, an estimated $1.94M.
  • Arjuna Capital first reported a position in Haemonetics in Q2 2018 and held it in 14 quarters.
  • Arjuna Capital's Haemonetics position peaked at $2.11M in Q4 2022.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q1 2024.

Based on Arjuna Capital's 13F filing for Q1 2024, filed 13 May 2024.